 CI, 0.50-3.04;
P ¼ .65) or major bleeding events (RR, 2.17; 95% CI, 0.1825.71; P ¼ .54). However, short-term combination therapy
was associated with a signiﬁcantly lower risk of major
vascular events (RR, 0.70; 95% CI, 0.69